Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Regulatory News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.12
Bid: 5.74
Ask: 6.50
Change: -0.12 (-1.92%)
Spread: 0.76 (13.24%)
Open: 6.24
High: 0.00
Low: 0.00
Prev. Close: 6.24
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Oct 2020 08:35

RNS Number : 3233D
Synairgen plc
27 October 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Synairgen plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Bong Koh and Nimish Shah (as the voting members of VHCP Management II, LLC and VHCP Management III, LLC)

 

City and country of registered office (if applicable)

New York, NY, U.S.A.

4. Full name of shareholder(s) (if different from 3.)v

Name

See section 11 below

City and country of registered office (if applicable)

New York, NY, U.S.A.

5. Date on which the threshold was crossed or reachedvi:

23 October 2020

6. Date on which issuer notified (DD/MM/YYYY):

27 October 2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.91%

3.91%

165,104,676

Position of previous notification (if

applicable)

4.64%

4.64%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

ISIN: GB00B0381Z20

6,455,000

3.91%

SUBTOTAL 8. A

6,455,000

3.91%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Bong Koh and Nimish Shah (as the voting members of VHCP Management II, LLC and VHCP Management III, LLC)

3.91%

N/A

3.91%

Bong Koh and Nimish Shah (as the votingmembers of VHCP Management II, LLC)

 

N/A

N/A

N/A

VHCP Management II, LLC

 

N/A

N/A

N/A

Bong Koh and Nimish Shah (as the votingmembers of VHCP Management III, LLC)

 

N/A

N/A

N/A

VHCP Management III, LLC

 

N/A

N/A

N/A

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Bong Koh and Nimish Shah are the voting members of VHCP Management II, LLC and VHCP Management III, LLC.

 

VCHP Management II, LLC is the general partner of Venrock Healthcare Capital Partners II, L.P. and manager of VHCP Co-Investment Holdings II, LLC, each of which holds shares in Synairgen plc falling below the notifiable threshold.

 

VHCP Management III, LLC is the general partner of Venrock Healthcare Capital Partners III, L.P. and manager of VHCP Co-Investment Holdings III, LLC, each of which holds shares in Synairgen plc falling below the notifiable threshold.

 

All percentages are based on the notified current issued share capital of Synairgen plc of 165,104,676 ordinary shares.

 

 

 

Place of completion

New York, NY, U.S.A.

Date of completion

27 October 2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFIFVTIVLDFII
Date   Source Headline
13th Nov 200812:15 pmRNSResult of AGM
7th Nov 20083:25 pmRNSChange of NOMAD
31st Oct 20089:00 amRNSTotal Voting Rights
20th Oct 20087:00 amRNSDirector/PDMR Shareholding and Additional Listing
10th Oct 20081:53 pmRNSPosting of 2008 Annual Report
8th Oct 20089:12 amRNSChange of Adviser Name
22nd Sep 20087:00 amRNSResearch Update
4th Aug 200810:00 amRNSDirector/PDMR Shareholding
31st Jul 20087:00 amRNSFinal Results
29th Jul 20087:00 amRNSCommencement of Clinical Tria
14th Jul 200811:48 amRNSNotice of Results
23rd May 20087:00 amRNSPresentation of data at ATS
13th Mar 20087:01 amRNSDirector Shareholding
12th Mar 20087:01 amRNSInterim Results
25th Feb 20087:01 amRNSNotice of Results
11th Feb 20087:01 amRNSPatent Granted
15th Nov 20077:01 amRNSResult of AGM
12th Nov 20078:25 amRNSContract with Alpha Biologics
31st Oct 200712:45 pmRNSDirector/PDMR Shareholding
28th Sep 20077:04 amRNSLicence/ Supply by Rentschler
26th Sep 20077:01 amRNSFinal Results
20th Aug 20077:00 amRNSNotice of Preliminary Results
17th Aug 20071:52 pmRNSAIM Rule 26
16th Aug 20072:54 pmRNSChange of Adviser
28th Jun 20072:30 pmRNSDirector/PDMR Shareholding
12th Jun 20077:02 amRNSResearch Update
20th Mar 20074:12 pmRNSHolding(s) in Company
19th Mar 20077:01 amRNSInterim Results
23rd Feb 20073:16 pmRNSHolding(s) in Company
13th Feb 20074:40 pmRNSNotice of Results
12th Dec 200611:55 amRNSTotal Voting Rights
30th Nov 20063:18 pmRNSDirector/PDMR Shareholding
15th Nov 20067:02 amRNSLicenses novel Peptide
8th Nov 200611:11 amRNSHolding(s) in Company
8th Nov 200610:21 amRNSDirector/PDMR Shareholding
18th Sep 20067:01 amRNSFinal Results
1st Sep 20067:00 amRNSNotice of Results
14th Aug 20067:04 amRNSLicensing Deal
14th Aug 20067:01 amRNSLicensing Agreement
24th May 20067:01 amRNSResearch Update
11th Apr 200612:56 pmRNSDirectorate Change
23rd Feb 20067:01 amRNSInterim Results
16th Jan 200611:00 amRNSNotice of Results
16th Nov 20053:40 pmRNSDirector/PDMR Shareholding
15th Nov 200512:15 pmRNSResult of AGM
15th Nov 20057:02 amRNSInterferon-Beta Enters Clinic
14th Nov 20057:00 amRNSChange of Adviser
27th Sep 20057:01 amRNSFinal Results
6th Sep 20059:00 amRNSNotice of Results
13th Jul 200511:18 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.